Phase I and pharmacologic study of oral (PEG-1000) 9-aminocamptothecin in adult patients with solid tumors.
de Jonge MJ, Punt CJ, Gelderblom AH, Loos WJ, van Beurden V, Planting AS, van der Burg ME, van Maanen LW, Dallaire BK, Verweij J, Wagener DJ, Sparreboom A.
de Jonge MJ, et al. Among authors: wagener dj.
J Clin Oncol. 1999 Jul;17(7):2219-26. doi: 10.1200/JCO.1999.17.7.2219.
J Clin Oncol. 1999.
PMID: 10561279
Clinical Trial.